Filing Details

Accession Number:
0001593968-21-001993
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-08-18 19:44:10
Reporting Period:
2021-08-16
Accepted Time:
2021-08-18 19:44:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1771917 Karuna Therapeutics Inc. KRTX Pharmaceutical Preparations (2834) 270605902
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1777760 Craig Andrew Miller C/O Karuna Therapeutics, Inc.
99 High Street, 26Th Floor
Boston MA 02110
Chief Operating Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-08-16 12,500 $2.92 58,000 No 4 M Direct
Common Stock Disposition 2021-08-16 1,379 $103.15 56,621 No 4 S Direct
Common Stock Disposition 2021-08-16 4,021 $104.14 52,600 No 4 S Direct
Common Stock Disposition 2021-08-16 100 $105.83 52,500 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option (right to buy) Disposition 2021-08-16 12,500 $0.00 12,500 $2.92
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
84,917 2026-10-11 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 15, 2021.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.67 to $103.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.72 to $104.65, inclusive.
  4. This option vested as to 1/16th of the shares underlying the option award on the vesting commencement date of July 18, 2016 and as to an additional 1/16th of the shares on each three month anniversary thereafter.